These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18772044)

  • 1. PTEN-5-HT2C coupling: a new target for treating drug addiction.
    Maillet JC; Zhang Y; Li X; Zhang X
    Prog Brain Res; 2008; 172():407-20. PubMed ID: 18772044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse.
    Ji SP; Zhang Y; Van Cleemput J; Jiang W; Liao M; Li L; Wan Q; Backstrom JR; Zhang X
    Nat Med; 2006 Mar; 12(3):324-9. PubMed ID: 16474401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tat-3L4F does not significantly affect spatial learning and memory.
    Li X; Zhang Y; Zhang X
    Behav Brain Res; 2008 Nov; 193(2):170-3. PubMed ID: 18571742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Synthetic Interfering Peptide Tat-3L4F Attenuates Olanzapine-Induced Weight Gain Through Disrupting Crosstalk Between Serotonin Receptor 2C and Protein Phosphatase and Tensin Homolog in Rats.
    Wang Y; Wang D; Chen Y; Fang X; Yu L; Zhang C
    Int J Neuropsychopharmacol; 2020 Nov; 23(8):481-490. PubMed ID: 32710540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular 5-HT 2C-receptor dephosphorylation: a new target for treating drug addiction.
    Müller CP; Carey RJ
    Trends Pharmacol Sci; 2006 Sep; 27(9):455-8. PubMed ID: 16876260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plot against pot.
    Thomas KL
    Nat Med; 2006 Mar; 12(3):281-3. PubMed ID: 16520773
    [No Abstract]   [Full Text] [Related]  

  • 7. Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior.
    Anastasio NC; Gilbertson SR; Bubar MJ; Agarkov A; Stutz SJ; Jeng Y; Bremer NM; Smith TD; Fox RG; Swinford SE; Seitz PK; Charendoff MN; Craft JW; Laezza FM; Watson CS; Briggs JM; Cunningham KA
    J Neurosci; 2013 Jan; 33(4):1615-30. PubMed ID: 23345234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Ventral Tegmental Area 5-HT
    Valencia-Torres L; Olarte-Sánchez CM; Lyons DJ; Georgescu T; Greenwald-Yarnell M; Myers MG; Bradshaw CM; Heisler LK
    Neuropsychopharmacology; 2017 Jun; 42(7):1511-1521. PubMed ID: 27882999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of serotonin 5-HT2C receptors in the ventral tegmental area.
    Bubar MJ; Cunningham KA
    Neuroscience; 2007 Apr; 146(1):286-97. PubMed ID: 17367945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration.
    Pierucci M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 2004 Apr; 309(1):109-18. PubMed ID: 14722316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
    Navailles S; Moison D; Ryczko D; Spampinato U
    J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine potentiates ethanol-induced excitation of dopaminergic reward neurons in the ventral tegmental area.
    Bunney EB; Appel SB; Brodie MS
    J Pharmacol Exp Ther; 2000 May; 293(2):383-9. PubMed ID: 10773006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain.
    Borsini F; Bordi F; Poggi A; Di Matteo V
    J Psychopharmacol; 2015 Jul; 29(7):802-11. PubMed ID: 25735994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LTP may trigger addiction.
    Wolf ME
    Mol Interv; 2003 Aug; 3(5):248-52. PubMed ID: 14993438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
    Narita M; Matsushima Y; Niikura K; Narita M; Takagi S; Nakahara K; Kurahashi K; Abe M; Saeki M; Asato M; Imai S; Ikeda K; Kuzumaki N; Suzuki T
    Addict Biol; 2010 Oct; 15(4):434-47. PubMed ID: 20731628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between 5-HT2cR and PTEN signaling pathway in atypical antipsychotic-induced metabolic syndrome and cognitive dysfunction.
    Cai J; Yi Z; Lu W; Fang Y; Zhang C
    Med Hypotheses; 2013 Apr; 80(4):486-9. PubMed ID: 23375407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of dopamine release by striatal 5-HT2C receptors.
    Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
    Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reinforcing actions of a serotonin-3 receptor agonist within the ventral tegmental area: evidence for subregional and genetic differences and involvement of dopamine neurons.
    Rodd ZA; Gryszowka VE; Toalston JE; Oster SM; Ji D; Bell RL; McBride WJ
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1003-12. PubMed ID: 17325230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serotonin 5-HT
    Canal CE; Murnane KS
    J Psychopharmacol; 2017 Jan; 31(1):127-143. PubMed ID: 27903793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin potentiates ethanol-induced excitation of ventral tegmental area neurons in brain slices from three different rat strains.
    Brodie MS; Trifunović RD; Shefner SA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1139-46. PubMed ID: 7791084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.